PrP assemblies

References

• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 144
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363 - 13383
   PubMed Web of Science ®Google Scholar
• Griffith JS. Self-replication and scrapie. Nature 1967; 215:1043 - 1044
   PubMed Web of Science ®Google Scholar
• Come JH, Fraser PE, Lansbury PT Jr. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 1993; 90:5959 - 5963
   PubMed Web of Science ®Google Scholar
• Jackson GS, Hosszu LL, Power A, Hill AF, Kenney J, Saibil H, et al. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science 1999; 283:1935 - 1937
   PubMed Web of Science ®Google Scholar
• Swietnicki W, Morillas M, Chen SG, Gambetti P, Surewicz WK. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 2000; 39:424 - 431
   PubMed Web of Science ®Google Scholar
• Rezaei H, Eghiaian F, Perez J, Doublet B, Choiset Y, Haertle T, et al. Sequential generation of two structurally distinct ovine prion protein soluble oligomers displaying different biochemical reactivities. J Mol Biol 2005; 347:665 - 679
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Amyloid formation by globular proteins under native conditions. Nat Chem Biol 2009; 5:15 - 22
   PubMed Web of Science ®Google Scholar
• Shmerling D, Hegyi I, Fischer M, Blattler T, Brandner S, Gotz J, et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 1998; 93:203 - 214
   PubMed Web of Science ®Google Scholar
• Calzolai L, Zahn R. Influence of pH on NMR structure and stability of the human prion protein globular domain. J Biol Chem 2003; 278:35592 - 35596
   PubMed Web of Science ®Google Scholar
• Eghiaian F, Daubenfeld T, Quenet Y, van Audenhaege M, Bouin AP, van der Rest G, et al. Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage. Proc Natl Acad Sci USA 2007; 104:7414 - 7419
   PubMed Web of Science ®Google Scholar
• Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci USA 1997; 94:10069 - 10074
   PubMed Web of Science ®Google Scholar
• Perez DR, Damberger FF, Wuthrich K. Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein. J Mol Biol 2010; 400:121 - 128
   PubMed Web of Science ®Google Scholar
• Sigurdson CJ, Nilsson KP, Hornemann S, Manco G, Fernandez-Borges N, Schwarz P, et al. A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest 2010; 120:2590 - 2599
   PubMed Web of Science ®Google Scholar
• Rezaei H, Choiset Y, Eghiaian F, Treguer E, Mentre P, Debey P, et al. Amyloidogenic unfolding intermediates differentiate sheep prion protein variants. J Mol Biol 2002; 322:799 - 814
   PubMed Web of Science ®Google Scholar
• Baskakov IV, Legname G, Prusiner SB, Cohen FE. Folding of prion protein to its native alpha-helical conformation is under kinetic control. J Biol Chem 2001; 276:19687 - 19690
   PubMed Web of Science ®Google Scholar
• Hafner-Bratkovic I, Bester R, Pristovsek P, Gaedtke L, Veranic P, Gaspersic J, et al. Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. J Biol Chem 2011; 286:12149 - 12156
   PubMed Web of Science ®Google Scholar
• Koshland DE. Application of a Theory of Enzyme Specificity to Protein Synthesis. Proc Natl Acad Sci USA 1958; 44:98 - 104
   PubMed Web of Science ®Google Scholar
• Wille H, Michelitsch MD, Guenebaut V, Supattapone S, Serban A, Cohen FE, et al. Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci USA 2002; 99:3563 - 3568
   PubMed Web of Science ®Google Scholar
• Morrissey MP, Shakhnovich EI. Evidence for the role of PrP(C) helix 1 in the hydrophilic seeding of prion aggregates. Proc Natl Acad Sci USA 1999; 96:11293 - 11298
   PubMed Web of Science ®Google Scholar
• Sawaya MR, Sambashivan S, Nelson R, Ivanova MI, Sievers SA, Apostol MI, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007; 447:453 - 457
   PubMed Web of Science ®Google Scholar
• Vanik DL, Surewicz KA, Surewicz WK. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol Cell 2004; 14:139 - 145
   PubMed Web of Science ®Google Scholar
• Tateishi J, Kitamoto T, Hoque MZ, Furukawa H. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology 1996; 46:532 - 537
   PubMed Web of Science ®Google Scholar
• Khan MQ, Sweeting B, Mulligan VK, Arslan PE, Cashman NR, Pai EF, et al. Prion disease susceptibility is affected by beta-structure folding propensity and local side-chain interactions in PrP. Proc Natl Acad Sci USA 2010; 107:19808 - 19813
   PubMed Web of Science ®Google Scholar
• Cobb NJ, Sonnichsen FD, McHaourab H, Surewicz WK. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci USA 2007; 104:18946 - 18951
   PubMed Web of Science ®Google Scholar
• Cobb NJ, Surewicz WK. Prion strains under the magnifying glass. Nat Struct Mol Biol 2007; 14:882 - 884
   PubMed Web of Science ®Google Scholar
• De Simone A, Zagari A, Derreumaux P. Structural and hydration properties of the partially unfolded states of the prion protein. Biophys J 2007; 93:1284 - 1292
   PubMed Web of Science ®Google Scholar
• Chakroun N, Prigent S, Dreiss CA, Noinville S, Chapuis C, Fraternali F, et al. The oligomerization properties of prion protein are restricted to the H2H3 domain. FASEB J 2010; 24:3222 - 3231
   PubMed Web of Science ®Google Scholar
• Adrover M, Pauwels K, Prigent S, de Chiara C, Xu Z, Chapuis C, et al. Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3. J Biol Chem 2010; 285:21004 - 21012
   PubMed Web of Science ®Google Scholar
• Lu X, Wintrode PL, Surewicz WK. Beta-sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchange. Proc Natl Acad Sci USA 2007; 104:1510 - 1515
   PubMed Web of Science ®Google Scholar
• Tycko R, Savtchenko R, Ostapchenko VG, Makarava N, Baskakov IV. The alpha-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel beta-sheet structure in PrP fibrils: Evidence from solid state nuclear magnetic resonance. Biochemistry 2010; 49:9488 - 9497
   PubMed Web of Science ®Google Scholar
• Kryndushkin DS, Wickner RB, Tycko R. The core of Ure2p prion fibrils is formed by the N-terminal segment in a parallel cross-beta structure: Evidence from solid-state NMR. J Mol Biol 2011; 409:263 - 277
   PubMed Web of Science ®Google Scholar
• Baskakov IV, Legname G, Baldwin MA, Prusiner SB, Cohen FE. Pathway complexity of prion protein assembly into amyloid. J Biol Chem 2002; 277:21140 - 21148
   PubMed Web of Science ®Google Scholar
• Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318:930 - 936
   PubMed Web of Science ®Google Scholar
• Gorbenko GP, Kinnunen PK. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem Phys Lipids 2006; 141:72 - 82
   PubMed Web of Science ®Google Scholar
• Morillas M, Swietnicki W, Gambetti P, Surewicz WK. Membrane environment alters the conformational structure of the recombinant human prion protein. J Biol Chem 1999; 274:36859 - 36865
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132 - 1135
   PubMed Web of Science ®Google Scholar
• Wang F, Yin S, Wang X, Zha L, Sy MS, Ma J. Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction. Biochemistry 2010; 49:8169 - 8176
   Google Scholar
• van der Kamp MW, Daggett V. The consequences of pathogenic mutations to the human prion protein. Protein Eng Des Sel 2009; 22:461 - 468
   PubMed Web of Science ®Google Scholar
• Kuwata K, Nishida N, Matsumoto T, Kamatari YO, Hosokawa-Muto J, Kodama K, et al. Hot spots in prion protein for pathogenic conversion. Proc Natl Acad Sci USA 2007; 104:11921 - 11926
   PubMed Web of Science ®Google Scholar
• Parchi P, Strammiello R, Giese A, Kretzschmar H. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present and future. Acta Neuropathol 2011; 121:91 - 112
   PubMed Web of Science ®Google Scholar
• Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 2007; 3:125
   PubMed Web of Science ®Google Scholar
• Chich JF, Chapuis C, Henry C, Vidic J, Rezaei H, Noinville S. Vesicle permeabilization by purified soluble oligomers of prion protein: a comparative study of the interaction of oligomers and monomers with lipid membranes. J Mol Biol 2010; 397:1017 - 1030
   PubMed Web of Science ®Google Scholar
• Noinville S, Chich JF, Rezaei H. Misfolding of the prion protein: linking biophysical and biological approaches. Vet Res 2008; 39:48
   PubMed Web of Science ®Google Scholar